Caltramag-D Tablet is primarily indicated in conditions like Hypocalcaemia of hypoparathyroidism, Hypoparathyroidism, Hypophosphataemia, Osteomalacia, Osteoporosis, Prevention of vitamin d deficiency, Renal osteodystrophy, Simple vitamin d deficiency, Vitamin D deficiency, Vitamin D deficiency rickets, and can also be given in adjunctive therapy as an alternative drug of choice in Malabsorption, Post gastrectomy vit B-12 deficiency, Renal diseases.
Caltramag-D Tablet is contraindicated in conditions like Hypercalcaemia.
The severe or irreversible adverse effects of Caltramag-D Tablet, which give rise to further complications include Cardiac arrhythmias, Cardiac arrhythmias, Paralytic ileus, Thirst, Dehydration, Polyuria, Nocturia, Abdominal pain, Overt psychosis, Metastatic calcification, Hyperphosphatemia, Hypervitaminosis D.Caltramag-D Tablet produces potentially life-threatening effects which include Cardiac arrhythmias, Renal failure. which are responsible for the discontinuation of Caltramag-D Tablet therapy. The symptomatic adverse reactions produced by Caltramag-D Tablet are more or less tolerable and if they become severe, they can be treated symptomatically, these include Weakness, Headache, Nausea, Vomiting, Anorexia, Apathy, Somnolence, Weakness.